SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Usana Health Sciences Inc. – ‘10-K’ for 12/30/23 – ‘EX-23.1’

On:  Tuesday, 2/27/24, at 4:26pm ET   ·   For:  12/30/23   ·   Accession #:  896264-24-93   ·   File #:  1-35024

Previous ‘10-K’:  ‘10-K’ on 2/28/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   14 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/27/24  Usana Health Sciences Inc.        10-K       12/30/23   95:9.5M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.77M 
 2: EX-21       Subsidiaries List                                   HTML     33K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     26K 
 8: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     34K 
                Awarded Compensation                                             
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     31K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     31K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     27K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     27K 
14: R1          Document And Entity Information                     HTML     99K 
15: R2          Consolidated Balance Sheets                         HTML    109K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     36K 
17: R4          Consolidated Statements of Comprehensive Income     HTML    122K 
18: R5          Consolidated Statements of Cash Flows               HTML    143K 
19: R6          Consolidated Statements of Stockholders' Equity     HTML     80K 
20: R7          Summary of Significant Accounting Policies          HTML    124K 
21: R8          Business Combinations                               HTML     31K 
22: R9          Inventories                                         HTML     36K 
23: R10         Prepaid Expenses and Other Current Assets           HTML     37K 
24: R11         Income Taxes                                        HTML    121K 
25: R12         Property and Equipment                              HTML     49K 
26: R13         Operating Leases                                    HTML     67K 
27: R14         Intangible Assets                                   HTML     75K 
28: R15         Other Current Liabilities                           HTML     38K 
29: R16         Line of Credit                                      HTML     35K 
30: R17         Commitments and Contingencies                       HTML     33K 
31: R18         Equity-Based Compensation                           HTML     98K 
32: R19         Segment Information                                 HTML     93K 
33: R20         Common Stock and Earnings Per Share                 HTML     46K 
34: R21         Schedule II - Valuation and Qualifying Accounts     HTML     57K 
35: R22         Significant Accounting Policies (Policies)          HTML    169K 
36: R23         Summary of Significant Accounting Policies          HTML     65K 
                (Tables)                                                         
37: R24         Inventories (Tables)                                HTML     36K 
38: R25         Prepaid Expenses and Other Current Assets (Tables)  HTML     37K 
39: R26         Income Taxes (Tables)                               HTML    122K 
40: R27         Property and Equipment (Tables)                     HTML     48K 
41: R28         Operating Leases (Tables)                           HTML     71K 
42: R29         Intangible Assets (Tables)                          HTML     80K 
43: R30         Other Current Liabilities (Tables)                  HTML     38K 
44: R31         Equity-Based Compensation (Tables)                  HTML     96K 
45: R32         Segment Information (Tables)                        HTML     96K 
46: R33         Common Stock and Earnings Per Share (Tables)        HTML     47K 
47: R34         Summary of Significant Accounting Policies -        HTML    111K 
                Narrative (Details)                                              
48: R35         Summary of Significant Accounting Policies -        HTML     58K 
                Schedule of Assets And Liabilities Measured At                   
                Fair Value (Details)                                             
49: R36         Summary of Significant Accounting Policies -        HTML     29K 
                Schedule of Other Revenue (Details)                              
50: R37         Summary of Significant Accounting Policies -        HTML     33K 
                Schedule of Contract Liabilities From Contract                   
                With Customers (Details)                                         
51: R38         Business Combinations (Details)                     HTML     54K 
52: R39         Inventories - Schedule of Inventories (Details)     HTML     38K 
53: R40         Inventories - Narrative (Details)                   HTML     32K 
54: R41         Prepaid Expenses and Other Current Assets -         HTML     42K 
                Prepaid Expenses and Other Current Assets                        
                (Details)                                                        
55: R42         Income Taxes - Consolidated Earnings Before Income  HTML     36K 
                Taxes (Details)                                                  
56: R43         Income Taxes - Income Tax Expense (Benefit)         HTML     55K 
                Included in Income from Continuing Operations                    
                (Details)                                                        
57: R44         Income Taxes - Effective Tax Rate Reconciliation    HTML     51K 
                (Details)                                                        
58: R45         Income Taxes - Significant Categories of Deferred   HTML     77K 
                Taxes (Details)                                                  
59: R46         Income Taxes - Narrative (Details)                  HTML     75K 
60: R47         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     38K 
61: R48         Property and Equipment - Cost of Property and       HTML     74K 
                Equipment and Estimated Useful Lives (Details)                   
62: R49         Property and Equipment - Narrative (Details)        HTML     28K 
63: R50         Operating Leases - Narrative (Details)              HTML     28K 
64: R51         Operating Leases - Classification of Lease Assets   HTML     46K 
                and Lease Liabilities (Details)                                  
65: R52         Operating Leases - Supplemental Lease Information   HTML     42K 
                (Details)                                                        
66: R53         Operating Leases - Maturity of Lease Liabilities    HTML     43K 
                (Details)                                                        
67: R54         Intangible Assets - Narrative (Details)             HTML     35K 
68: R55         Intangible Assets - Changes in Carrying Amounts of  HTML     38K 
                Goodwill (Details)                                               
69: R56         Intangible Assets - Estimated Amortization Expense  HTML     42K 
                (Details)                                                        
70: R57         Intangible Assets - Intangible Assets (Details)     HTML     57K 
71: R58         Other Current Liabilities - Other Current           HTML     43K 
                Liabilities (Details)                                            
72: R59         Line of Credit - Narrative (Details)                HTML     46K 
73: R60         Commitments and Contingencies - Narrative           HTML     44K 
                (Details)                                                        
74: R61         Equity-Based Compensation - Narrative (Details)     HTML    126K 
75: R62         Equity-Based Compensation - Remaining Unrecognized  HTML     36K 
                Compensation Expense (Details)                                   
76: R63         Equity-Based Compensation - Weighted-average        HTML     47K 
                Assumptions (Details)                                            
77: R64         Equity-Based Compensation - Summary of              HTML     68K 
                Stock-settled Stock Appreciation Right Activity                  
                (Details)                                                        
78: R65         Equity-Based Compensation - Summary of              HTML     51K 
                Stock-settled Restricted Stock Unit Activity                     
                (Details)                                                        
79: R66         Equity-Based Compensation - Summary of              HTML     51K 
                Cash-settled Restricted Stock Unit Activity                      
                (Details)                                                        
80: R67         Equity-Based Compensation - Schedule of             HTML     40K 
                Performance Stock Units Valuation Assumptions                    
                (Details)                                                        
81: R68         Equity-Based Compensation - Schedule of             HTML     53K 
                Market-Based and Performance-Based Conditions                    
                (Details)                                                        
82: R69         Segment Information - Additional Information        HTML     28K 
                (Details)                                                        
83: R70         Segment Information - Schedule of Segment           HTML     37K 
                Reporting Information, by Operating Segment                      
                (Details)                                                        
84: R71         Segment Information - Schedule of Revenue           HTML     40K 
                Percentage By Product (Details)                                  
85: R72         Segment Information - Consolidated Net Sales and    HTML     57K 
                Long Lived Assets (Details)                                      
86: R73         Segment Information - Markets Representing Ten      HTML     41K 
                Percent Or More Of Consolidated Net Sales and                    
                Long-Lived Assets (Details)                                      
87: R74         Common Stock and Earnings Per Share - Schedule of   HTML     53K 
                Earnings Per Share (Details)                                     
88: R75         Common Stock and Earnings Per Share - Schedule of   HTML     29K 
                Shares not Included in the Computation of Diluted                
                EPS (Details)                                                    
89: R76         Common Stock and Earnings Per Share - Narrative     HTML     35K 
                (Details)                                                        
90: R77         Schedule II - Valuation and Qualifying Accounts -   HTML     42K 
                Valuation and Qualifying Accounts (Details)                      
92: XML         IDEA XML File -- Filing Summary                      XML    168K 
95: XML         XBRL Instance -- usna-20231230_htm                   XML   2.01M 
91: EXCEL       IDEA Workbook of Financial Report Info              XLSX    171K 
10: EX-101.CAL  XBRL Calculations -- usna-20231230_cal               XML    248K 
11: EX-101.DEF  XBRL Definitions -- usna-20231230_def                XML    583K 
12: EX-101.LAB  XBRL Labels -- usna-20231230_lab                     XML   2.00M 
13: EX-101.PRE  XBRL Presentations -- usna-20231230_pre              XML   1.14M 
 9: EX-101.SCH  XBRL Schema -- usna-20231230                         XSD    193K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              554±   848K 
94: ZIP         XBRL Zipped Folder -- 0000896264-24-000093-xbrl      Zip    602K 


‘EX-23.1’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-96645, 333-128103, 333-133385, 333-174695, and 333-206070) on Form S-8 and (No. 333-169946) on Form S-3 of our reports dated February 27, 2024, with respect to the consolidated financial statements and financial statement schedule II of USANA Health Sciences, Inc. and the effectiveness of internal control over financial reporting.
/s/ KPMG LLP
Salt Lake City, Utah
February 27, 2024


Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/27/24None on these Dates
For Period end:12/30/23
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/07/24  Usana Health Sciences Inc.        10-Q        3/30/24   56:3.4M


13 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/08/22  Usana Health Sciences Inc.        10-Q       10/01/22   58:8.4M
 5/11/22  Usana Health Sciences Inc.        10-Q        4/02/22   54:3.3M                                   RDG Filings/FA
11/10/21  Usana Health Sciences Inc.        10-Q       10/02/21   55:4.1M                                   RDG Filings/FA
 5/11/21  Usana Health Sciences Inc.        10-Q        4/03/21   53:3.4M                                   RDG Filings/FA
 3/02/21  Usana Health Sciences Inc.        10-K        1/02/21   91:10M                                    RDG Filings/FA
 8/27/20  Usana Health Sciences Inc.        8-K:1,9     8/25/20   12:4.4M                                   Business Wire/FA
 3/15/19  Usana Health Sciences Inc.        8-K:5,9     3/14/19    2:183K                                   Business Wire/FA
 2/26/19  Usana Health Sciences Inc.        10-K       12/29/18   92:11M                                    Toppan Merrill-FA
 7/31/15  Usana Health Sciences Inc.        8-K:5,9     7/31/15    7:263K                                   Toppan Merrill-FA
11/09/11  Usana Health Sciences Inc.        10-Q       10/01/11   34:5M                                     Toppan Merrill/FA
12/30/10  Usana Health Sciences Inc.        8-A12B                 1:29K                                    Toppan Merrill/FA
 5/24/06  Usana Health Sciences Inc.        8-K:1,9     5/22/06    3:77K                                    Business Wire/FA
 4/25/06  Usana Health Sciences Inc.        8-K:1,5,9   4/19/06    4:142K                                   Business Wire/FA
Top
Filing Submission 0000896264-24-000093   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 1:03:29.2pm ET